Sarepta Therapeutics (NQ: SRPT )
145.61
+1.83
(+1.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Headline News about Sarepta Therapeutics
![](https://cdn.benzinga.com/files/images/story/2024/01/09/aapharma_4.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/02/bmbl1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/12/srpt-stock.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/09/acuity_brands_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/760055/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Sarepta Therapeutics
December 12, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/756930/gettyimages-1016186674.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Sarepta Therapeutics
November 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/Genetic-Research-And-Biotech-Science-Con.jpeg?width=1200&height=800&fit=crop)
![](https://staticx-tuner.zacks.com/images/default_article_images/default35.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://g.foolcdn.com/editorial/images/759359/biotech-pharma-researchers-talk-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/753371/doctor-and-patient-in-a-hospital-room.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Sarepta Therapeutics
November 02, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/758683/vertex.png)
![](https://g.foolcdn.com/editorial/images/758222/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://g.foolcdn.com/editorial/images/757305/tracking-investments-wealth-family-planning.jpg)
![](https://g.foolcdn.com/editorial/images/755403/dna-on-monitor-scientists.jpg)
![](https://investorplace.com/wp-content/uploads/2021/05/bank-lending-capital-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/15/ctlt.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/15/jim_cramer_shutter4.jpg?width=1200&height=800&fit=crop)
Jim Cramer Likes Founder Of AI Company, But Stock Is 'Losing A Fortune' And There's 'Too Much Hype There'
November 15, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://g.foolcdn.com/editorial/images/753878/a-frustrated-investor-reviewing-multiple-charts-and-reports.jpg)
![](https://g.foolcdn.com/editorial/images/753979/worried-investor-watching-stock-graph-trend-down.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2020/04/Stock-bullfightingbear-01-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript
November 02, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/images/story/2023/10/31/aapharma_10.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.